P14.125 Retrospective analysis of long-term response to bevacizumab in combination with irinotecan for recurrent glioblastoma: identification of prognostic factors

BACKGROUND: In absence of standard treatment for recurrent glioblastoma (rGBM), numerous prospective and retrospective studies have evaluated the off-label combination of bevacizumab (BEV) with irinotecan (IRI) in patients with rGBM. We report here our single center experience with this combination...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuro Oncol
Huvudupphovsmän: Besson, C, Morisse, M, Brut, H, Waissi, W, Noel, G, Chauffert, B, Prébay, D, Schott, R, Etienne-Selloum, N
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2019
Ämnen:
Poster Presentations
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795168/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.360
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk